Overview
Oxygen is an element displayed by the symbol O, and atomic number 8. It is an essential element for human survival. Decreased oxygen levels may be treated with medical oxygen therapy. Treatment with oxygen serves to increase blood oxygen levels and also exerts a secondary effect of decreasing blood flow resistance in the diseased lung, leading to decreased cardiovascular workload in an attempt to oxygenate the lungs. Oxygen therapy is used to treat emphysema, pneumonia, some heart disorders (congestive heart failure), some disorders that cause increased pulmonary artery pressure, and any disease that impairs the body's ability to take up and use gaseous oxygen. Higher level of oxygen than ambient air (hyperoxia) can be introduced under normobaric or hyperbaric conditions.
Indication
Oxygen therapy in clinical settings is used across diverse specialties, including various types of anoxia, hypoxia or dyspnea and any other disease states and conditions that reduce the efficiency of gas exchange and oxygen consumption such as respiratory illnesses, trauma, poisonings and drug overdoses. Oxygen therapy tries to achieve hyperoxia to reduce the extent of hypoxia-induced tissue damage and malfunction.
Associated Conditions
- Anemia
- Cancer
- Hypoxemia
- Hypoxia
- Migraine
- Polycythemia
- Pulmonary Hypertension (PH)
- Respiratory Disorders
- Sleep Apnea
Research Report
Oxygen (DB09140): A Comprehensive Monograph on its Chemistry, Pharmacology, and Clinical Application
Section I: Introduction and Historical Context: From "Dephlogisticated Air" to Essential Medicine
Oxygen, the most abundant element in the Earth's crust, occupies a unique and paradoxical position within the modern pharmacopeia. It is simultaneously a fundamental component of the atmosphere essential for all aerobic life and a potent, regulated prescription drug with a defined therapeutic window and significant potential for toxicity. This dual identity—as both a life-sustaining substrate and a powerful therapeutic agent—frames the central challenge of its clinical application: the judicious use of a substance that can be life-saving when correcting hypoxia but life-threatening when administered in excess. The journey of oxygen from an unknown component of air to a cornerstone of medical therapy is a story of scientific revolution, contested discovery, and evolving understanding that mirrors the maturation of chemistry and medicine itself. This report provides a comprehensive monograph on oxygen (DrugBank ID: DB09140), detailing its history, physicochemical properties, complex pharmacology, diverse clinical applications, methods of administration, safety profile, and the unique regulatory framework that governs its use.
The scientific understanding of oxygen emerged from an intellectual landscape dominated by the phlogiston theory. In the 18th century, this theory posited that all combustible materials contained a fire-like element called "phlogiston," which was released during burning. What we now call oxidation was then understood as the release of phlogiston, and the remaining ash or calx was considered "dephlogisticated". It was within this paradigm that the first investigations into the nature of air and combustion took place, setting the stage for one of chemistry's most pivotal discoveries.[1]
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/06/17 | Not Applicable | Active, not recruiting | |||
2025/05/06 | Not Applicable | Not yet recruiting | |||
2025/01/29 | Phase 2 | Recruiting | Bernardino Clavo, MD, PhD | ||
2024/12/18 | Phase 1 | Recruiting | |||
2024/11/26 | Phase 2 | Recruiting | Bernardino Clavo, MD, PhD | ||
2024/11/26 | Early Phase 1 | Active, not recruiting | |||
2024/10/30 | Phase 1 | Active, not recruiting | |||
2024/10/16 | Not Applicable | Recruiting | |||
2024/10/10 | Phase 2 | Recruiting | |||
2024/08/30 | Phase 3 | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Island Equipment Company | 50153-110 | RESPIRATORY (INHALATION) | 99 L in 100 L | 11/2/2023 | |
AMERICAN GASES CORPORATION | 82606-001 | RESPIRATORY (INHALATION) | 990 mL in 1 L | 7/19/2022 | |
Timberlake Respiratory Care and Home Medical | 54292-123 | RESPIRATORY (INHALATION) | 99 L in 100 L | 10/22/2019 | |
Dickinson Home Medical Equipment | 19979-000 | RESPIRATORY (INHALATION) | 1 L in 1 L | 10/19/2022 | |
A.V. Pulmonary Care | 63398-1072 | RESPIRATORY (INHALATION) | 99 L in 100 L | 1/1/2010 | |
Monroe Welding Supply, Inc. | 52233-001 | RESPIRATORY (INHALATION) | 992 mL in 1 L | 8/24/2010 | |
ROBINSON`S INDUSTRIAL GAS & EQUIPMENT CORP. | 66487-001 | RESPIRATORY (INHALATION) | 997 mL in 1 L | 10/10/2023 | |
One Home Medical Equipment, LLC | 73266-001 | RESPIRATORY (INHALATION) | 99 L in 100 L | 10/20/2023 | |
CENTRAL NEBRASKA HOME CARE SERVICES | 12201-001 | RESPIRATORY (INHALATION) | 210 mL in 1 L | 12/27/2017 | |
Indiana Oxygen Company Inc | 48546-0006 | RESPIRATORY (INHALATION) | 99 L in 100 L | 2/11/2022 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
AIR LIQUIDE AUSTRALIA LIMITED Nitronox 50% Nitrous Oxide and 50% Oxygen Mixture Gas Medicinal | 32752 | Medicine | A | 11/1/1991 | |
AIR LIQUIDE AUSTRALIA LIMITED Oxygen 100% v/v Bulk Liquid, Gas Medicinal | 32744 | Medicine | A | 11/1/1991 | |
Coregas Pty Ltd medical oxygen 100% v/v gas in gas cylinder | 34472 | Medicine | A | 1/2/1992 | |
HELIOX 28 oxygen/helium 28/72% v/v medical gas mixture | 90662 | Medicine | A | 8/21/2003 | |
MEDICAL MIXTURE, OXYGEN/HELIUM | 34473 | Medicine | A | 1/2/1992 | |
BOC GASES ENTONOX OXYGEN 50%v/v and NITROUS OXIDE 50%v/v MIXTURE, Gas Medicinal | 34470 | Medicine | A | 1/2/1992 | |
EQUANOX medical nitrous oxide 50% v/v and oxygen 50% v/v gas in gas cylinder | 27141 | Medicine | A | 10/21/1991 | |
Coregas Pty Ltd medical oxygen (liquid) 100%v/v in bulk containers | 199515 | Medicine | A | 1/17/2013 | |
BOC GASES OXYGEN 99.5% MEDICAL EP GRADE gas medicinal | 34468 | Medicine | A | 1/2/1992 | |
CARBOGEN 5% CARBON DIOXIDE IN OXYGEN MIXTURE | 34469 | Medicine | A | 1/2/1992 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
MEDICAL AIR | matheson gas products canada inc. | 00581143 | Gas - Inhalation | 23.5 % | 12/31/1983 |
PRAIRIE OXYGEN USP | prairie oxygen ltd | 02312131 | Gas - Inhalation | 99 % | 6/5/2008 |
OXYGEN | cair co. respiratory services inc. | 02248682 | Gas - Inhalation | 99 % | 5/3/2004 |
OXYGEN U.S.P. | all-can medical inc. | 00896683 | Gas - Inhalation | 99.9 % | 8/11/1990 |
OXYFIT GAS 99.5% | maag technic ag | 00679267 | Gas - Inhalation | 99.5 % | 12/31/1986 |
CARBON DIOXIDE IN OXYGEN MIXTURE | matheson gas products canada inc. | 00460907 | Gas - Inhalation | 90 % | 12/31/1983 |
CARBON DIOXIDE 1% W OXYGEN | liquid carbonic inc. | 00882747 | Gas - Inhalation | 93 % | 12/31/1990 |
LUNG DIFFUSION TEST MIXTURE | matheson gas products canada inc. | 00580759 | Gas - Inhalation | 23 % | 12/31/1982 |
HELIUM / OXYGEN MIXTURE | 02154846 | Gas - Inhalation | 50 % / V/V | 12/31/1995 | |
OXYGEN USP | emrn oxygène | 02242533 | Gas - Inhalation | 99 % | 7/31/2000 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.